Chris Lo

All articles by Chris Lo

1. Debate: can US pharma be taxed into behaving?

   As Democratic candidates jockey for position in the campaign to win their party’s nomination in the 2020 US presidential race,…
   Read More…

   2 Jan
2. Bias remorse: are cancer drug trials clear enough on outcomes?

   With cancer cases on the rise globally, partly driven by the world’s growing and ageing population, it’s understandable that drug…
   Read More…

   19 Dec
3. Public image limited: the role of PR in pharma

   The pharma industry operates at the sensitive intersection between medicine and money. While pharmaceutical products save countless lives every year…
   Read More…

   18 Dec
4. Nobel Prize 2019: how a breathtaking discovery unlocked new drugs

   “It is not easy to convey, unless one has experienced it, the dramatic feeling of sudden enlightenment that floods the…
   Read More…

   17 Dec
5. The dengue vaccine dilemma

   The Philippines is in the midst of a national epidemic of dengue fever, a mosquito-borne tropical disease that causes flu-like…
   Read More…

   16 Dec
6. Debate: should countries bring critical drug production home?

   Chris Lo: countries must consider all options for safe API production, including repatriation The pharmaceutical supply chain is an incredibly…
   Read More…

   27 Nov
7. Herd health: agriculture’s role in the global AMR crisis

   In 2019, few would deny that the rising trend of antimicrobial resistance (AMR) represents a global health crisis. Decades of…
   Read More…

   13 Nov
8. Cancer drug discovery: unravelling the mysteries of halichondrin

   In June, the Kishi Lab at Harvard University’s Department of Chemistry and Chemical Biology made an important announcement. A team…
   Read More…

   5 Nov
9. WHO’s Essential Medicines List: discussing innovation and access

   In April this year, the World Health Organization’s (WHO) Expert Committee on the Selection and Use of Essential Medicines met…
   Read More…

   2 Oct
10. Trouble at Teva: US price-fixing lawsuit adds to generic giant’s woes

    Teva Pharmaceutical Industries is a titan of Israel’s pharmaceutical industry. Over the last 30 years the company has evolved into…
    Read More…

    1 Aug